A detailed history of Northern Trust Corp transactions in Eyenovia, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 261,078 shares of EYEN stock, worth $169,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
261,078
Previous 253,250 3.09%
Holding current value
$169,700
Previous $526,000 50.95%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.99 - $2.37 $7,749 - $18,552
7,828 Added 3.09%
261,078 $258,000
Q4 2023

Feb 13, 2024

BUY
$1.08 - $2.08 $12,697 - $24,454
11,757 Added 4.87%
253,250 $526,000
Q3 2023

Nov 13, 2023

BUY
$1.57 - $2.54 $9,553 - $15,455
6,085 Added 2.58%
241,493 $400,000
Q2 2023

Aug 11, 2023

BUY
$2.21 - $5.75 $401,954 - $1.05 Million
181,880 Added 339.78%
235,408 $557,000
Q1 2023

May 15, 2023

BUY
$1.72 - $3.53 $30,093 - $61,760
17,496 Added 48.56%
53,528 $188,000
Q4 2022

Feb 13, 2023

BUY
$1.54 - $2.06 $9,130 - $12,213
5,929 Added 19.7%
36,032 $58,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $2.48 $4,770 - $7,633
3,078 Added 11.39%
30,103 $59,000
Q4 2021

Feb 08, 2022

SELL
$3.5 - $6.58 $8,963 - $16,851
-2,561 Reduced 8.66%
27,025 $108,000
Q1 2021

May 12, 2021

BUY
$5.11 - $7.41 $5,927 - $8,595
1,160 Added 4.08%
29,586 $151,000
Q4 2020

Feb 11, 2021

BUY
$3.11 - $6.06 $12,912 - $25,161
4,152 Added 17.1%
28,426 $172,000
Q2 2020

Aug 14, 2020

BUY
$2.6 - $3.81 $2,082 - $3,051
801 Added 3.41%
24,274 $69,000
Q3 2019

Nov 13, 2019

BUY
$2.55 - $4.91 $11,727 - $22,581
4,599 Added 24.37%
23,473 $87,000
Q2 2019

Aug 13, 2019

SELL
$4.08 - $6.87 $3,406 - $5,736
-835 Reduced 4.24%
18,874 $81,000
Q1 2019

May 13, 2019

BUY
$2.63 - $6.3 $51,834 - $124,166
19,709 New
19,709 $118,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $22.2M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.